Legal Representation
Attorney
Robert D. Ward
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 6, 2018 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Feb 6, 2018 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Aug 7, 2017 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Aug 7, 2017 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 6, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 4, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 4, 2017 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 4, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 5, 2016 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 18, 2016 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| May 10, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 10, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 20, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 6, 2016 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Apr 5, 2016 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 18, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 17, 2016 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 17, 2016 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 17, 2016 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 17, 2016 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 16, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 2, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 28, 2015 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Pharmaceutical research, drug discovery, and drug development services; medical and scientific research in the field of pulmonary diseases; research and development of pharmaceutical preparations for the treatment of pulmonary diseases and disorders; research and development of pharmaceutical preparations and substances for treatment of respiratory conditions; research and development of new products in the field of surfactant replacement therapies for respiratory diseases; research and development of pharmaceutical preparations, namely, pulmonary lung surfactants; pharmaceutical research and development in the field of inhaled pharmaceutical products for all human respiratory indications; research and development services in the field of medical apparatus, appliances and instruments for producing and/or delivering aerosolized pharmaceutical preparations; providing scientific information about pharmaceutical products and services; providing scientific information about pharmaceutical products and services via a website and other forms of media
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
042